Management of dermatologic adverse events from cancer therapies: recommendations of an expert panel (2020)
- Authors:
- USP affiliated authors: LINS, JADE CURY MARTINS ASFORA - FM ; SANCHES JUNIOR, JOSE ANTONIO - FM
- Unidade: FM
- DOI: 10.1016/j.abd.2020.01.001
- Subjects: ANTINEOPLÁSICOS; DROGA (VÍCIO); NEOPLASIAS; FATORES DE RISCO; PELE; DOENÇAS DA PELE E DO TECIDO CONJUNTIVO
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Anais brasileiros de dermatologia
- ISSN: 0365-0596
- Volume/Número/Paginação/Ano: v. 95, n. 2, p. 221-237, 2020
- Este artigo possui versão em acesso aberto
- URL de acesso aberto
- PDF de acesso aberto
- Versão do Documento: Versão publicada (Published version)
-
Status: Artigo publicado em periódico de acesso aberto (Gold Open Access) -
ABNT
LINS, Jade Cury Martins Asfora et al. Management of dermatologic adverse events from cancer therapies: recommendations of an expert panel. Anais brasileiros de dermatologia, v. 95, n. 2, p. 221-237, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.abd.2020.01.001. Acesso em: 10 mar. 2026. -
APA
Lins, J. C. M. A., Eris, A. P. M., Abdalla, C. M. Z., Silva, G. de B., Moura, V. P. T. de, & Sanches Junior, J. A. (2020). Management of dermatologic adverse events from cancer therapies: recommendations of an expert panel. Anais brasileiros de dermatologia, 95( 2), 221-237. doi:10.1016/j.abd.2020.01.001 -
NLM
Lins JCMA, Eris APM, Abdalla CMZ, Silva G de B, Moura VPT de, Sanches Junior JA. Management of dermatologic adverse events from cancer therapies: recommendations of an expert panel [Internet]. Anais brasileiros de dermatologia. 2020 ; 95( 2): 221-237.[citado 2026 mar. 10 ] Available from: https://doi.org/10.1016/j.abd.2020.01.001 -
Vancouver
Lins JCMA, Eris APM, Abdalla CMZ, Silva G de B, Moura VPT de, Sanches Junior JA. Management of dermatologic adverse events from cancer therapies: recommendations of an expert panel [Internet]. Anais brasileiros de dermatologia. 2020 ; 95( 2): 221-237.[citado 2026 mar. 10 ] Available from: https://doi.org/10.1016/j.abd.2020.01.001 - Perforating dermatosis associated with multikinase inhibitors [Carta]: report of two cases, including one associated with lenvatinib
- Acquired lipodystrophy associated with nivolumab in a patient with advanced renal cell carcinoma
- Acquired lipodystrophy associated with nivolumab in a patient with advanced renal cell carcinoma
- A unique case of a lymphoproliferative disorder affecting the skin and uterine cervix on a male transgender
- Patient-reported quality of life in patients with relapsed/refractory cutaneous T-cell lymphoma: Results from the randomised phase III ALCANZA study
- Dermoscopy of primary cutaneous B- and T-cell lymphomas and pseudolymphomas presenting as solitary nodules and tumors: a case-control study with histopathologic correlation
- Case for diagnosis. Erythematous-violaceous reticulated plaques on the breasts [Editorial]
- Folliculotropic mycosis fungoides: clinical and epidemiological evaluation in a single center in Brazil
- Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial
- Consensuses, guidelines and position papers [Editorial]: the role of the Brazilian Society of Dermatology in the contribution to the best practice of Dermatology
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
